Adjuvant chemotherapy improves overall survival in resectable stage I-III duodenal adenocarcinoma patients
After Surgery, This Extra Step May Extend Survival in Rare Cancer
This retrospective cohort study evaluated 98 patients with resectable stage I-III duodenal adenocarcinoma at two Chinese institutions.
After surgery for duodenal cancer, adding chemotherapy may nearly double survival time, but larger trials are still needed.
